J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on April 1, 2004

Papers In Press, published online ahead of print January 16, 2004
J. Lipid Res., doi:10.1194/jlr.M300363-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M300363-JLR200v1
45/4/674    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tai, E. S.
Right arrow Articles by Ordovas, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tai, E. S.
Right arrow Articles by Ordovas, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on August 28, 2003
Revised on January 5, 2004
Accepted on January 6, 2004

Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population: the 1998 Singapore National Health Survey

E. Shyong Tai, Dolores Corella, Mabel Deurenberg-Yap, Xian Adiconis, Suok Kai Chew, Chee Eng Tan, and Jose M. Ordovas

Department of Nutrition and Genomics, Tufts University, Boston, MA 02111

Corresponding Author: jose.ordovas{at}tufts.edu

We have investigated the association of C1431T and Pro12Ala polymorphisms at the peroxisome proliferator-activated receptor g (PPARg) locus with plasma lipids and insulin resistance-related variables, according to diabetes status, in a large and representative Asian population from Singapore consisting of 2730 Chinese, 740 Malays and 568 Asian-Indians. Moreover, we estimated the diabetes risk and examined gene-nutrient interactions between these variants and the ratio of polyunsaturated fat (PUFA) to saturated fat (SFA) in determining body mass index (BMI) and fasting insulin. We have found differential effect of these gene variants. The Pro12Ala polymorphism was more associated with plasma lipids and fasting glucose concentrations, whereas, the C1431T polymorphism was related to the risk of diabetes. Carriers of the 12Ala allele had higher HDL-C than Pro12Pro homozygotes (P<0.05), and the effect of the 12Ala allele on fasting glucose was modified by the diabetes status (P<0.001). After controlling for confounders, carriers of the T allele had decreased risk of diabetes as compared with CC homozygotes (OR:0.73; 95%CI, 0.58-0.93; P=0.011); this effect was stronger in Asian Indians. For both polymorphisms, normal subjects carrying the less prevalent allele had higher BMI (P<0.05). The PUFA/SFA did not modify the effect of these polymorphisms on BMI or insulin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
E. A Ruiz-Narvaez, P. Kraft, and H. Campos
Ala12 variant of the peroxisome proliferator-activated receptor-{gamma} gene (PPARG) is associated with higher polyunsaturated fat in adipose tissue and attenuates the protective effect of polyunsaturated fat intake on the risk of myocardial infarction
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1238 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. C. Florez, K. A. Jablonski, M. W. Sun, N. Bayley, S. E. Kahn, H. Shamoon, R. F. Hamman, W. C. Knowler, D. M. Nathan, D. Altshuler, et al.
Effects of the Type 2 Diabetes-Associated PPARG P12A Polymorphism on Progression to Diabetes and Response to Troglitazone
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1502 - 1509.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Tonjes, M. Scholz, M. Loeffler, and M. Stumvoll
Association of Pro12Ala Polymorphism in Peroxisome Proliferator-Activated Receptor {gamma} With Pre-Diabetic Phenotypes: Meta-analysis of 57 studies on nondiabetic individuals.
Diabetes Care, November 1, 2006; 29(11): 2489 - 2497.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.-P. Koh, J.-M. Yuan, D. Van Den Berg, S. A. Ingles, and M. C. Yu
Peroxisome proliferator-activated receptor (PPAR) {gamma} gene polymorphisms and colorectal cancer risk among Chinese in Singapore
Carcinogenesis, September 1, 2006; 27(9): 1797 - 1802.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. Radha, K. S. Vimaleswaran, H. N. S. Babu, N. Abate, M. Chandalia, P. Satija, S. M. Grundy, S. Ghosh, P. P. Majumder, R. Deepa, et al.
Role of Genetic Polymorphism Peroxisome Proliferator-Activated Receptor-{gamma}2 Pro12Ala on Ethnic Susceptibility to Diabetes in South-Asian and Caucasian Subjects: Evidence for heterogeneity
Diabetes Care, May 1, 2006; 29(5): 1046 - 1051.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
E Ruiz-Narvaez
Is the Ala12 variant of the PPARG gene an "unthrifty allele"?
J. Med. Genet., July 1, 2005; 42(7): 547 - 550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.